Examining mineral levels in pregnant women
Evaluation of Mineral Status in Pregnant Women and Its Association With Fetal Development
Poznan University of Life Sciences · NCT03598361
This study looks at how the levels of important minerals in pregnant women affect their pregnancy and the development of their babies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 550 (estimated) |
| Sex | Female |
| Sponsor | Poznan University of Life Sciences (other) |
| Locations | 1 site (Poznan) |
| Trial ID | NCT03598361 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the correlation between the mineral status of pregnant women and various pregnancy outcomes. It will analyze mineral concentrations in maternal blood serum, amniotic fluid, and hair, while also collecting dietary data through questionnaires and nutrition journals. The study focuses on understanding how deficiencies or excesses of essential minerals like iron, calcium, zinc, magnesium, and copper may impact fetal development and the overall course of pregnancy. By identifying these relationships, the research seeks to contribute to better nutritional guidelines and prenatal care.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women diagnosed with a single intrauterine pregnancy before 14 weeks gestation, without any complications or use of medications affecting mineral metabolism.
Not a fit: Patients with ectopic pregnancies, multiple pregnancies, or those with a history of significant obstetric complications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional recommendations for pregnant women, potentially enhancing pregnancy outcomes and fetal health.
How similar studies have performed: Previous studies have indicated relationships between mineral status and pregnancy outcomes, suggesting that this approach has potential based on existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosed intrauterine pregnancy until week 14. 2. Single pregnancy without congenital malformations in ultrasound examination. 3. Lack of exponents threatening miscarriage (bleeding, lower abdominal pain, chorionic hematoma). 4. Lack of use of drugs affecting the mineral metabolism of the body. 5. Signing consent to participate in the study. Exclusion Criteria: 1. Ectopic or heterotopic pregnancy. 2. Twin pregnancy (or other multiple pregnancy). 3. Obstetric load in the direction of numerous miscarriages, premature births under 34 weeks, pregnancy, fetal growth disorders (hypotrophy, macrosomia). 4. Congenital and /or genetic defects found in current pregnancy or in the patient. 5. Supply of drugs affecting the mineral metabolism of the body.
Where this trial is running
Poznan
- Poznan University of Life Sciences — Poznan, Poland (RECRUITING)
Study contacts
- Study coordinator: Joanna Suliburska, Assoc. Prof.
- Email: jsulibur@up.poznan.pl
- Phone: +48 618487344
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pregnancy, Disorder, Blood, pregnancy outcomes, minerals